Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial - Concepedia

Concepedia

Publication | Open Access

Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial

DOI Full Paper Access

43

Citations

16

References

2023

Year

Gregory G. Schwartz, Michael Szarek, Deepak L. Bhatt, Vera Bittner, Maja Bujas‐Bobanovic, Rafael Díaz, Sergio Fazio, Zlatko Fras, Shaun G. Goodman, Robert A. Harrington,

European Heart Journal

Abstract

ClinicalTrials.gov NCT01663402.

References

	Year	Citations

Page 1